Patents for A61P 19 - Drugs for skeletal disorders (81,981)
02/2009
02/24/2009US7494977 Polypeptides homologous to VEGF and BMP1
02/24/2009US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
02/24/2009CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds
02/24/2009CA2262582C Hcg and derivatives as matrix metalloproteases inhibitors
02/24/2009CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins
02/20/2009CA2597900A1 Arthritis gone
02/19/2009WO2009023854A1 Bicyclic sphingosine 1-phosphate analogs
02/19/2009WO2009023707A1 Method of treating disease involving myelin and/or axonal loss
02/19/2009WO2009022720A1 Five-membered heterocyclic compound
02/19/2009WO2009022687A1 Phenylacetic acid compound
02/19/2009WO2009022179A2 Glucokinase activators in the treatment of osteoarthritis
02/19/2009WO2009021980A1 α-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS
02/19/2009WO2009021704A1 Repair of lesions in cartilage and bone using a chondro-regulative matrix
02/19/2009WO2009021696A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
02/19/2009WO2009021661A1 Composition for the prophylaxis and treatment of osteoporosis
02/19/2009WO2008155520A3 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain
02/19/2009WO2008152423A3 Treatment of inflammation or autoimmune diseases with sulphated compounds
02/19/2009WO2008018827A8 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
02/19/2009US20090049561 Non-human animal exhibiting bone metastasis of tumor cells
02/19/2009US20090048412 Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs
02/19/2009US20090048338 Biologically active oils
02/19/2009US20090048313 enzyme synthetase, ligase and/or kinase inhibitors such as N-(3-(diethylamino)propyl)-N-(4-(2,5-dimethoxyphenyl)thiazol-2-yl)benzamide, used for treating Alzheimer's disease, strokes, diabetes, obesity, inflammation, cancer and rheumatoid arthritis
02/19/2009US20090048308 VLA-4 Antagonists
02/19/2009US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
02/19/2009US20090048236 New phenylalanine derivatives
02/19/2009US20090048226 Inhibitors of caspases
02/19/2009US20090048224 Compounds and methods of use
02/19/2009US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient
02/19/2009US20090048167 Disease treatment via antimicrobial peptides or their inhibitors
02/19/2009US20090048157 Use of organic compounds
02/19/2009US20090048145 In situ hardening paste, its manufacturing and use
02/19/2009US20090047360 Bone morphogenic protein binding peptide
02/19/2009US20090047287 Modulation of bone formation
02/19/2009US20090047275 Modulating calvarial osteoblast differentiation; fracture repair
02/19/2009US20090047261 Composition For Treatment Of Articular Cartilage Damage
02/19/2009US20090047241 Il-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation
02/19/2009US20090047240 Chaperonin 10-induced immunomodulation
02/19/2009US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby
02/19/2009DE102007039310A1 Zusammensetzung zur Prophylaxe und Behandlung von Osteoporose Composition for the prophylaxis and treatment of osteoporosis
02/19/2009CA2820566A1 Dhea compositions for treating menopause
02/19/2009CA2696488A1 Bicyclic sphingosine 1-phosphate analogs
02/19/2009CA2696310A1 Method of treating disease involving myelin and/or axonal loss
02/19/2009CA2696177A1 Repair of lesions in cartilage and bone using a chondro-regulative matrix
02/19/2009CA2695878A1 5-membered heterocyclic compound
02/19/2009CA2695757A1 Phenylacetic acid compound
02/19/2009CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
02/18/2009EP2025752A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen
02/18/2009EP2025749A1 Humanized anti-human osteopontin antibody
02/18/2009EP2025676A1 Novel indazole derivative having spiro ring structure in side chain
02/18/2009EP2025669A1 Alpha-alkyl substituted N-acyltryptophanols
02/18/2009EP2025666A2 Thiolalkyl benzoic acid derivatives
02/18/2009EP2024335A1 Novel imidazole derivatives, preparation and user thereof as medicine
02/18/2009EP1569635B1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
02/18/2009EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases
02/18/2009EP1208097B1 Substituted oxoazaheterocyclyl compounds
02/18/2009EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents
02/18/2009CN101371142A Method of diagnosis and method of treatment
02/18/2009CN101370773A Cycloalkanecarboxamide derivative and method for producing same
02/18/2009CN101366934A Preparation method of pill for clearing and activating the channels and collaterals
02/18/2009CN101366919A Traditional Chinese medicine ointment for treating rheumatism diseases
02/18/2009CN101366891A Medicine pillow for preventing and controlling cervical spondylosis and preparation method thereof
02/18/2009CN101366890A Chinese medicinal composition of medicinal pillow for treating cervical spondylosis
02/18/2009CN101366889A Plaster for treating rheumatic arthritis and preparation method
02/18/2009CN101366887A Externally washing traditional Chinese medicine preparation for detumescence and dissipation blood stasis
02/18/2009CN101366843A Traditional Chinese medicine pain-relieving powder prescription
02/18/2009CN101366814A Novel medicament for treating systematic lupus erythematosus
02/18/2009CN101366732A Preparation of full-natural centipede dry powder
02/18/2009CN101366730A Glucosamine donkey-hide gelatin product and preparation method thereof
02/18/2009CN101366729A Method for preparing bone peptide extract and products thereby
02/18/2009CN101366721A Bulk medicament for treating orthopedic disorders and preparation method thereof
02/18/2009CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament
02/18/2009CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/18/2009CN100462351C Amino acids with affinity for the alpha-2-delta-protein
02/18/2009CN100462098C Chinese medicine ointment for treating bone disease and its preparing method
02/18/2009CN100462093C Powder for setting a broken bone and preparation method
02/17/2009US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD)
02/17/2009US7491796 Retro-inversion peptides that target GIT receptors and related methods
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491740 Isoxazoline compounds having MIF antagonist activity
02/17/2009US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease
02/17/2009US7491691 Bone and/or cartilage development-stimulating peptide incorporating proline or hydroxyproline; implants
02/17/2009US7491677 Composite sample on support; concentration gradients
02/17/2009US7491514 High specificity antibodies with reduce immunogenicity; evaluative and diagnostic tools; immunotherapy
02/17/2009US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis
02/17/2009US7491389 Bone marrow; controlling cell differentiation
02/17/2009CA2445189C Carboline derivatives as pdev inhibitors
02/17/2009CA2400217C Pteridine compounds for the treatment of psoriasis
02/17/2009CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
02/17/2009CA2348380C Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
02/12/2009WO2009020534A2 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines
02/12/2009WO2009020483A1 Crystalline forms of ibandronate sodium
02/12/2009WO2009020234A2 Pyrrolidin-2 -one derivatives as androgen receptor modulator
02/12/2009WO2009019503A2 P2x7 antagonists for use in the treatment of mood disorders
02/12/2009WO2009019473A1 Treatments for inflammatory arthritis
02/12/2009WO2009019167A1 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
02/12/2009WO2009018613A1 Methods of generating, repairing and/or maintaining connective tissue in vivo
02/12/2009WO2008071605A3 Methods of treating inflammatory diseases
02/12/2009US20090043399 Use of fucans for the purpose of bone grafting, engineering and regeneration
02/12/2009US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
02/12/2009US20090042913 Indolylalkylthienopyrimidylamines as modulators of the EP2 receptor